respiratori
viru
infect
rvi
pediatr
solid
organ
transplant
sot
recipi
pose
signific
risk
howev
epidemiolog
effect
rvi
pediatr
sot
era
current
molecular
diagnost
assay
unclear
method
retrospect
observ
cohort
pediatr
sot
recipi
januari
june
assembl
us
pediatr
transplant
center
chart
review
rvi
event
associ
hospit
within
year
transplant
rvi
diagnosi
requir
respiratori
symptom
detect
viru
ie
human
rhinovirusenteroviru
human
metapneumoviru
influenza
viru
parainfluenza
viru
coronaviru
andor
respiratori
syncyti
viru
incid
rvi
calcul
associ
baselin
sot
factor
subsequ
pulmonari
complic
death
assess
result
pediatr
sot
recipi
liver
kidney
heart
lung
intestinemultiviscer
develop
rvi
associ
hospit
within
month
transplant
rvi
occur
highest
rate
intestin
abdomin
multiviscer
thorac
heartlung
liver
transplant
recipi
lower
rate
kidney
transplant
recipi
rvi
associ
younger
median
age
transplant
vs
year
p
among
liver
kidney
transplant
recipi
receipt
deceaseddonor
graft
compar
live
donor
p
allcaus
attribut
casefat
rate
within
month
rvi
onset
respect
multivari
logist
regress
model
reveal
age
independ
associ
increas
risk
pulmonari
complic
odd
ratio
confid
interv
receipt
intestinemultiviscer
transplant
associ
increas
risk
allcaus
death
odd
ratio
confid
interv
conclus
studi
hospitalassoci
rvi
common
first
year
pediatr
sot
associ
younger
age
transplant
allcaus
death
rvi
rare
definit
attribut
death
occur
respiratori
viru
infect
rvi
lead
caus
hospit
children
result
signific
morbid
death
among
immunocompromis
children
includ
undergon
solid
organ
transplant
sot
howev
much
literatur
regard
rvi
pediatr
sot
limit
singlecent
report
focus
viral
pathogen
combin
sot
recipi
immunocompromis
host
even
data
highrisk
pediatr
lung
transplant
patient
limit
singl
multicent
studi
report
epidemiolog
rvi
popul
perform
period
robust
molecular
diagnost
lack
contemporari
data
specif
rvi
pediatr
sot
recipi
import
knowledg
gap
especi
era
molecular
diagnost
comprehens
understand
frequenc
outcom
rvi
patient
popul
particularli
within
first
year
sot
immunosuppress
highest
help
guid
futur
investig
rvi
manag
identifi
need
novel
prevent
treatment
strategi
larg
multicent
retrospect
cohort
pediatr
sot
recipi
assembl
determin
incid
rvi
hospit
first
year
transplant
identifi
factor
associ
poor
outcom
patient
rvi
studi
cohort
compris
children
year
old
underw
kidney
liver
heart
lung
heartlung
intestinemultiviscer
ie
intestin
along
abdomin
organ
includ
liver
andor
pancrea
transplant
januari
june
us
pediatr
academ
institut
sot
recipi
follow
day
transplant
day
transplant
death
loss
followup
whichev
occur
first
primari
outcom
presenc
rvi
associ
hospit
within
day
sot
definit
rvi
includ
follow
criteria
posit
result
respiratori
viral
pathogen
nasopharyng
swab
aspir
nasal
wash
specimen
sputum
tracheal
aspir
deep
bronchial
wash
bronchoalveolar
lavag
specimen
document
clinic
sign
respiratori
ill
includ
cough
rhinorrhea
andor
increas
work
breath
within
hour
posit
respiratori
viru
test
rvi
detect
either
hospit
prompt
admiss
symptom
posit
test
result
follow
respiratori
pathogen
consid
rhinovirusenteroviru
human
metapneumoviru
hmpv
influenza
parainfluenza
viru
piv
respiratori
syncyti
viru
rsv
coronaviru
diagnost
test
rhinoviru
hmpv
influenza
piv
rsv
avail
center
studi
period
test
coronaviru
avail
particip
center
pathogen
record
viru
detect
given
rvi
episod
case
recurr
rvi
event
viru
first
episod
document
unless
subsequ
episod
occur
day
first
event
least
neg
intercurr
test
result
number
day
transplant
rvi
onset
assign
basi
day
sampl
result
posit
respiratori
viru
test
result
collect
patient
document
rvi
follow
month
onset
infect
assess
subsequ
respiratori
support
pulmonari
complic
death
death
occur
within
month
rvi
onset
evalu
attribut
attribut
caus
death
like
possibl
like
attribut
rvi
assign
central
review
independ
investig
deidentifi
summari
circumst
surround
patient
death
institut
review
board
approv
studi
site
investig
train
research
assist
retrospect
abstract
prioriidentifi
data
element
includ
demograph
pretranspl
transplant
perirvi
variabl
directli
central
redcap
electron
databas
host
duke
univers
primari
aim
studi
determin
incid
rvi
pathogen
rhinoviru
hmpv
influenza
piv
rsv
coronaviru
associ
hospit
within
first
year
transplant
univari
logist
regress
analys
perform
assess
associ
variou
baselin
host
characterist
risk
factor
time
transplant
subsequ
develop
rvi
secondari
aim
studi
determin
allcaus
attribut
casefat
rate
rvi
onset
identifi
factor
associ
pulmonari
complic
death
month
rvi
casefat
rate
calcul
proport
patient
rvi
die
within
month
rvi
onset
multivari
logist
regress
model
construct
use
outcom
pulmonari
complic
death
postrvionset
period
model
limit
pulmonari
complic
death
event
howev
follow
factor
hypothes
priori
potenti
associ
outcom
age
need
respiratori
support
baselin
histori
chronic
lung
diseas
variabl
assess
univari
logist
regress
analysi
includ
multivari
logist
regress
model
statist
calcul
perform
use
stata
stata
corp
colleg
station
texa
retrospect
identif
sot
recipi
particip
center
result
final
cohort
subject
median
patient
age
tabl
organ
transplant
includ
liver
kidney
heart
lung
intestineabdomin
multiviscer
one
hundr
fiftynin
sot
recipi
rvi
event
associ
hospit
within
first
year
transplant
respiratori
virus
detect
rvi
occur
highest
rate
intestineabdomin
multiviscer
transplant
follow
heart
lung
liver
kidney
transplant
earliest
rvi
event
occur
median
day
transplant
iqr
day
minim
variabl
time
across
virus
piv
case
rsv
hmpv
influenza
piv
rhinoviru
infect
hmpv
influenza
rsv
occur
primarili
autumn
winter
wherea
piv
rhinoviru
occur
throughout
calendar
year
tabl
figur
n
predomin
occur
throughout
year
wherea
n
n
cluster
fall
winter
month
respect
clinic
sign
frequent
associ
respiratori
viru
detect
includ
fever
within
hour
lower
respiratori
tract
diseas
onset
fever
common
influenza
least
common
hmpv
piv
rsv
first
rvi
event
patient
least
rvi
patient
neutropen
absolut
neutrophil
count
cellsml
sever
lymphopen
absolut
lymphocyt
count
cellsml
week
onset
howev
absolut
lymphocyt
count
rvi
onset
avail
patient
underli
chronic
lung
diseas
need
respiratori
support
includ
oxygen
noninvas
mechan
ventil
admiss
intens
care
unit
rvi
diagnosi
rel
common
respect
antivir
agent
direct
identifi
pathogen
prescrib
case
influenza
rsv
rhinoviru
specif
patient
rsv
receiv
ribavirin
alon
wherea
anoth
receiv
palivizumab
alon
patient
rhinoviru
receiv
intraven
immunoglobulin
g
ribavirin
intraven
immunoglobulin
g
administ
patient
within
week
rvi
onset
hmpv
influenza
piv
rsv
rhinoviru
patient
diagnos
least
rvi
significantli
younger
patient
without
rvi
median
year
iqr
vs
year
iqr
p
recipi
liver
kidney
deceas
donor
significantli
like
rvi
recipi
liver
kidney
live
donor
vs
respect
p
diagnosi
rvi
otherwis
associ
sex
race
organtranspl
type
influenza
vaccin
rate
also
similar
patient
without
influenza
vs
respect
subsequ
first
rvi
event
subject
patient
experienc
pulmonari
complic
ie
tracheostomi
subacut
pulmonari
sequela
chronic
pulmonari
sequela
bronchiol
obliteran
pulmonari
complic
seven
patient
die
within
month
rvi
onset
allcaus
case
fatal
rate
tabl
death
like
attribut
rsv
event
possibl
attribut
piv
event
notabl
intestin
transplant
recipi
develop
rvi
die
death
possibl
relat
rvi
death
occur
rvi
onset
isol
liver
kidney
recipi
liver
recipi
develop
pulmonari
complic
pulmonari
hemorrhag
within
month
rvi
onset
therefor
multivari
logist
regress
model
use
assess
factor
associ
pulmonari
complic
death
within
month
rvi
exclud
liver
kidney
recipi
tabl
within
subset
sot
recipi
first
rvi
onset
rvi
within
day
transplant
odd
ratio
confid
interv
ci
respiratori
support
baselin
ci
associ
increas
risk
pulmonari
complic
within
month
univari
analysi
neither
remain
associ
pulmonari
complic
multivari
model
tabl
receipt
intestin
multiviscer
abdomin
transplant
associ
death
within
month
rvi
onset
addit
patient
pulmonari
complic
die
rvi
onset
white
receiv
steroid
week
rvi
preclud
inclus
covari
regress
model
knowledg
largest
studi
date
multicent
pediatr
cohort
hospitalassoci
rvi
first
year
sot
evalu
overal
pediatr
sot
recipi
least
document
rvi
requir
hospit
within
month
transplant
highest
rate
rvi
seen
intestineabdomin
multiviscer
transplant
recipi
lowest
rate
occur
kidney
transplant
recipi
overal
incid
similar
rvi
rate
report
previou
studi
larg
cohort
pediatr
lung
transplant
recipi
despit
fact
earlier
cohort
evalu
routin
avail
molecular
diagnost
rhinoviru
account
event
cohort
consist
recent
report
rvi
etiolog
adult
sot
recipi
substanti
increas
rate
studi
initi
molecular
diagnost
death
rvi
rel
uncommon
studi
occur
first
rvi
event
death
deem
possibl
like
relat
rvi
comparison
mortal
rate
previous
publish
literatur
suggest
declin
mortal
rate
rvi
among
sot
recipi
data
singlecent
cohort
assembl
reveal
casefat
rate
influenza
piv
note
followup
among
pediatr
sot
recipi
influenza
pandem
gener
treat
antivir
therapi
reveal
death
aforement
multicent
pediatr
lung
transplant
cohort
report
casefat
rate
among
patient
rvi
howev
death
cohort
lung
transplant
recipi
occur
adenoviru
infect
evalu
studi
might
result
reduc
estim
mortal
rate
adenoviru
associ
increas
risk
death
popul
pediatr
transplant
recipi
decis
exclud
adenoviru
infect
studi
relat
abil
dissemin
result
system
ill
set
apart
typic
rvi
pulmonari
complic
least
complic
within
mo
diagnosi
chronic
pulmonari
sequela
pulmonari
complic
observ
recipi
kidney
liver
transplant
live
donor
decreas
risk
rvi
compar
whose
graft
came
deceas
donor
interest
phenomenon
pediatr
kidney
transplant
live
donor
might
schedul
occur
period
lower
risk
rvi
summer
month
although
data
specif
support
supposit
institut
approv
studi
requir
anonym
data
includ
date
transplant
rvi
event
cohort
occur
period
mirror
rvi
circul
commun
decreas
number
event
summer
month
could
decreas
risk
earli
rvi
hospitalassoci
rvi
risk
hospit
decreas
time
transplant
popul
anoth
possibl
hypothesi
would
differ
immunosuppress
protocol
recipi
livingdonor
graft
effect
except
pediatr
lung
transplant
past
literatur
rvi
sot
recipi
limit
mainli
singlecent
report
studi
focus
pathogen
organ
often
includ
patient
undergo
transplant
compar
previou
literatur
provid
case
sot
acquir
full
denomin
data
larg
cohort
enabl
calcul
rvi
incid
rate
pediatr
sot
recipi
particip
institut
includ
howev
result
must
interpret
view
certain
limit
given
retrospect
natur
studi
protocol
consist
evalu
rvi
follow
even
patient
admit
hospit
respiratori
ill
addit
misclassif
bia
possibl
although
chart
review
systemat
decreas
possibl
rvi
event
occur
outpati
set
necessit
hospit
admiss
captur
known
mani
sot
recipi
receiv
outpati
care
clinic
outsid
transplant
center
patient
well
transplant
might
like
receiv
care
center
farther
transplant
center
thu
captur
inpati
event
might
underestim
true
rate
rvi
popul
specif
data
regard
acut
transplant
reject
collect
cohort
limit
potenti
evalu
possibl
associ
rvi
subsequ
reject
intensifi
immunosuppress
last
although
larg
cohort
assembl
evalu
patient
varieti
transplant
organ
includ
number
rvi
subsequ
event
pulmonari
complic
death
still
rel
small
limit
abil
identifi
signific
risk
factor
poor
outcom
multivari
analys
overal
rvi
associ
hospit
common
first
year
pediatr
sot
higher
rate
associ
younger
age
intestineabdomin
multiviscer
transplant
particularli
interest
contrast
earlier
report
allcaus
death
rvi
rare
although
death
definit
attribut
rvi
complic
occur
common
among
patient
requir
supplement
respiratori
support
time
diagnosi
method
reduc
effect
rvi
pediatr
sot
need
includ
novel
prevent
treatment
option
vulner
patient
